GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » EV-to-Revenue

Ibex Technologies (TSXV:IBT) EV-to-Revenue : 3.52 (As of Jun. 09, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ibex Technologies's enterprise value is C$28.17 Mil. Ibex Technologies's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was C$8.00 Mil. Therefore, Ibex Technologies's EV-to-Revenue for today is 3.52.

The historical rank and industry rank for Ibex Technologies's EV-to-Revenue or its related term are showing as below:

TSXV:IBT' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.02   Med: 0.54   Max: 3.68
Current: 3.52

During the past 13 years, the highest EV-to-Revenue of Ibex Technologies was 3.68. The lowest was 0.02. And the median was 0.54.

TSXV:IBT's EV-to-Revenue is ranked better than
69.33% of 1037 companies
in the Biotechnology industry
Industry Median: 7.86 vs TSXV:IBT: 3.52

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-09), Ibex Technologies's stock price is C$1.44. Ibex Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.30. Therefore, Ibex Technologies's PS Ratio for today is 4.78.


Ibex Technologies EV-to-Revenue Historical Data

The historical data trend for Ibex Technologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies EV-to-Revenue Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.67 0.80 0.45 3.01

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.08 2.06 3.01 2.25 2.54

Competitive Comparison of Ibex Technologies's EV-to-Revenue

For the Biotechnology subindustry, Ibex Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's EV-to-Revenue falls into.



Ibex Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ibex Technologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=28.172/7.998
=3.52

Ibex Technologies's current Enterprise Value is C$28.17 Mil.
Ibex Technologies's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$8.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibex Technologies  (TSXV:IBT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ibex Technologies's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.44/0.301
=4.78

Ibex Technologies's share price for today is C$1.44.
Ibex Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibex Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines